Citius Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:CTXR) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -16.93 M-24.25 M-28.36 M-29.06 M-28.2 M-26.55 M -31.6 M Cash from investing activities -1 831-40.01 M0-8.83 M-5 M-5.75 M -3.63 M Cash from financing activities 22.9 M120.47 M013.83 M9.97 M33.3 M 46.91 M Free cash flow -16.93 M-24.25 M-28.36 M-29.06 M-28.2 M-26.55 M -31.6 M

News

Gold Edges Lower; Omeros Shares Jump - AMC Entertainment Hldgs (NYSE:AMC), Citius Pharmaceuticals (NASDAQ:CTXR)

Dow Gains Over 100 Points; US Jobless Claims Decline - Citius Pharmaceuticals (NASDAQ:CTXR), Multi Ways Holdings (AMEX:MWG)

Stock Market Today: Dow Jones, S&P 500 Futures Drop On Christmas Eve Despite Strong Q3 GDP Report—UiPath, AST SpaceMobile, Ramaco Resources In Focus - SPDR S&P 500 (ARCA:SPY)

Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why

Citius Pharma launches cancer immunotherapy LYMPHIR in the U.S.

Citius Oncology stock tumbles after $18M capital raise

Citius Oncology stock soars on expanded AI collaboration for LYMPHIR launch

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Coeur Mining (NYSE:CDE), First Majestic Silver (NYSE:AG)

Curanex Pharmaceuticals closes $15 million IPO on NASDAQ

Curanex Pharmaceuticals prices IPO at $4 per share

Citius Oncology deploys AI platform to support LYMPHIR launch

Citius Oncology files prospectus supplement to update S-1 registration